More
Monoclonal Antibodies

Monoclonal Antibodies

Cancer immunotherapy is an advanced treatment approach that activates the patient's immune system to combat tumor cells. Unlike conventional methods (chemotherapy, radiation therapy), immunotherapy utilizes natural immune mechanisms to recognize and destroy cancer.
Immune Checkpoint Inhibitors
Drugs (e.g., pembrolizumab, nivolumab) block proteins that prevent immune cells from attacking tumors (e.g., PD-1, CTLA-4).

CAR T-cell Therapy
Patient's T-lymphocytes are genetically modified to recognize and eliminate cancer cells.

Monoclonal Antibodiesа
Targeted antibodies (e.g., rituximab, trastuzumab) specifically bind to proteins expressed by cancer cells.

 Cytokines and Immunostimulants
Proteins (e.g., interleukins, interferons) enhance immune system activity against cancer.

— Cancer Vaccines
Stimulate immune response against tumor-specific antigens (e.g., Sipuleucel-T vaccine for prostate cancer).
High Specificity
Targets tumors while sparing healthy tissues.

Long-term Protection
Immune system develops memory against cancer cells, preventing recurrence.

Effectiveness Against Chemotherapy-resistant Tumors

We are developing innovative experimental drugs for cancer treatment.
Main Types of Immunotherapy:
Key Advantages

Cancer Immunotherapy

Would you like us to develop a custom drug?

Leave your request, and we will contact you.
Сообщение об успешной отправке!